IFN-β regulates anti-tumor immunity by enhancing the sensitivity of tumor cells to Fas-mediated apoptosis; reducing their ability to evade immune attack; and inhibiting their malignant proliferation [37, 38]. The gene discussed is IFNB1; the disease is neoplasm.